From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, S Pedersoli-Mantoani, C Roca… - European Journal of …, 2017 - Elsevier
The lack of an effective treatment for Alzheimer'disease (AD), an increasing prevalence and
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
[引用][C] From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, SP Mantoani, C Roca… - European Journal of …, 2017 - repositorio.usp.br
ReP USP - Detalhe do registro: From dual binding site acetylcholinesterase inhibitors to
allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease Home …
allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease Home …
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, S Pedersoli-Mantoani, C Roca… - EUROPEAN …, 2017 - bv.fapesp.br
The lack of an effective treatment for Alzheimer'disease (AD), an increasing prevalence and
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
TPC Chierrito, S Pedersoli-Mantoani… - European Journal of …, 2017 - europepmc.org
The lack of an effective treatment for Alzheimer'disease (AD), an increasing prevalence and
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
[引用][C] From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, S Pedersoli-Mantoani, C Roca… - European Journal of …, 2017 - cir.nii.ac.jp
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue
for disease-modifying drugs in Alzheimer's disease | CiNii Research CiNii 国立情報学研究所 …
for disease-modifying drugs in Alzheimer's disease | CiNii Research CiNii 国立情報学研究所 …
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, S Pedersoli-Mantoani… - European journal …, 2017 - pubmed.ncbi.nlm.nih.gov
The lack of an effective treatment for Alzheimer'disease (AD), an increasing prevalence and
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
TPC Chierrito, S Pedersoli-Mantoani, C Roca… - EUROPEAN …, 2017 - bv.fapesp.br
The lack of an effective treatment for Alzheimer'disease (AD), an increasing prevalence and
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …
severe neurodegenerative pathology boost medicinal chemists to look for new drugs …